Current Status of Tricuspid Valve Interventions in Asia Pacific Region

Area of Science:

• Cardiology
• Interventional Cardiology
• Heart Failure Management

Background:

• Transcatheter tricuspid interventions are increasingly adopted in the Asia Pacific region.
• Numerous novel transcatheter tricuspid technologies have been developed and utilized over the past decade.
• Symptomatic tricuspid regurgitation diagnosis and treatment access remain suboptimal.

Purpose of the Study:

• To highlight the growing use of transcatheter tricuspid interventions in Asia Pacific.
• To identify the need for a standardized clinical algorithm for diagnosing symptomatic tricuspid regurgitation.
• To discuss challenges and opportunities in delivering novel right heart therapies in the region.

Main Methods:

• Review of current trends in transcatheter tricuspid interventions in Asia Pacific.
• Analysis of existing diagnostic approaches for tricuspid regurgitation.
• Discussion of patient population diversity and healthcare system factors.

Main Results:

• Significant increase in the adoption of transcatheter tricuspid interventions across Asia Pacific.
• Lack of a standardized clinical algorithm for diagnosing symptomatic tricuspid regurgitation.
• Unique challenges including patient anatomy, disease prevalence, and socioeconomic factors impact treatment.

Conclusions:

• A standardized diagnostic algorithm is crucial to enhance patient access to transcatheter tricuspid therapies.
• Addressing regional specificities is key to successful implementation of right heart failure treatments.
• Advancements in technology and treatment strategies hold promise for wider patient benefit globally.